Neutrophil-to-Albumin Ratio Predicts Stroke-Associated Pneumonia in Patients with Intracerebral Hemorrhage

中性粒细胞与白蛋白比值可预测脑出血患者发生卒中相关性肺炎的风险

阅读:1

Abstract

BACKGROUND AND AIM: Pneumonia is a significant complication that negatively impacts outcomes in patients with intracerebral hemorrhage (ICH). Identifying reliable biomarkers for predicting such infections is crucial for timely intervention and improving patient management. This study aims to evaluate the predictive value of neutrophil-to-albumin Ratio (NAR)for pneumonia in patients undergoing surgical intervention for ICH. METHODS: This was a retrospective multicenter cohort study conducted at four tertiary hospitals. A total of 8016 patients diagnosed with spontaneous intracerebral hemorrhage (ICH) between were included. The neutrophil-to-albumin ratio (NAR) was calculated within 24 hours of admission. Logistic regression models, receiver operating characteristic (ROC) curves, and reclassification metrics (C-index, IDI, cNRI) were used to evaluate the association between NAR and the risk of pneumonia. The primary outcome was pneumonia. RESULTS: A total of 8016 ICH patients were included in this study. Among them, 3921 patients (48.9%) had pneumonia. There was an association between NAR levels and pneumonia (OR = 1.81, 95% CI: 1.69-1.94, p < 0.001). After adjustment, the results remained significant (adjusted OR = 1.62, 95% CI: 1.51-1.75, p < 0.001). Compared to patients in the Low Group (NAR ≤ 0.21), those in the High Group (NAR > 0.21) had a higher long-term mortality risk (OR = 2.95, 95% CI: 2.68-3.24, p < 0.001; adjusted OR = 1.99, 95% CI: 1.79-2.21, p < 0.001). Additionally, the predictive performance of NAR for pneumonia was also significant (area under the ROC curve [95% CI] 0.663 [0.651-0.675]; p < 0.001). CONCLUSION: Higher NAR is independently associated with pneumonia in patients with ICH. The early prediction of pneumonia using the simple biomarker NAR is feasible.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。